Profil
Doug Gentilcore formerly worked at Jubilant DraxImage, Inc., as Vice President-Global Sales & Business Operations, Y-mAbs Therapeutics, Inc., as Senior VP & Head-Danyelza Business Unit in 2025, and ARTMS, Inc., as Chief Commercial Officer.
Mr. Gentilcore received his undergraduate degree from Randolph-Macon College.
Ehemalige bekannte Positionen von Doug Gentilcore
| Unternehmen | Position | Ende |
|---|---|---|
| YMAS THER | Corporate Officer/Principal | 16.09.2025 |
Jubilant Draximage, Inc.
Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes radiopharmaceuticals products for heart, thyroid, lung & bone disease | Vertrieb & Marketing | - |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Vorstandsvorsitzender | - |
Ausbildung von Doug Gentilcore
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Randolph-Macon College
Randolph-Macon College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jubilant Draximage, Inc.
Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes radiopharmaceuticals products for heart, thyroid, lung & bone disease | Health Technology |
Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
















